Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $94.5100 (-0.37%) ($94.1800 - $95.2350) on Mon. Aug. 24, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.34% (three month average) | RSI | 51 | Latest Price | $94.5100(-0.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.4% a day on average for past five trading days. | Weekly Trend | ABBV advances 1.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(49%) SPLV(38%) VYM(36%) DIA(34%) XLP(34%) | Factors Impacting ABBV price | ABBV will decline at least -0.67% in a week (0% probabilities). VIXM(-24%) UUP(-9%) VXX(-6%) TLT(-2%) EDOC(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.67% (StdDev 1.34%) | Hourly BBV | -0.8 () | Intraday Trend | -0.4% | | | |
|
Resistance Level | $94.82 | 5 Day Moving Average | $95.26(-0.79%) | 10 Day Moving Average | $95.08(-0.6%) | 20 Day Moving Average | $94.82(-0.33%) | To recent high | -6.3% | To recent low | 5% | Market Cap | $166.742b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |